Stay updated on Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page.

Latest updates to the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new release entry 'Revision: v3.6.3' has been added to the study's history, and the previous 'Revision: v3.6.0' has been removed. This reflects an update to the page's underlying release notes.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe history now shows that recruitment has ended ('No longer looking for participants') and logs a new revision (v3.6.0) while removing the prior revision entry (v3.5.5).SummaryDifference0.4%

- Check33 days agoChange DetectedA new release entry, v3.5.5, appears in the record history, replacing v3.5.4. This indicates a background update to the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page's Revision label changed from v3.5.3 to v3.5.4 to reflect a new site release; no other study content or details appear to be modified.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page footer’s software/application revision indicator was updated from v3.5.0 to v3.5.3.SummaryDifference0.1%

- Check112 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the history. This is a page-version update rather than a change to trial content or results.SummaryDifference0.1%

Stay in the know with updates to Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page.